injectables

Injectables


Injectables

Our injectable portfolio includes small molecules, peptides & recombinant proteins. These products would be manufactured in our 'Fill & Finish' sterile plant.

Product Strength
Octreotide Injection 50, 100, 500mcg/ml single dose (1ml in 2ml Vial)
Octreotide Injection 200, 1000mcg/ml Multidose Vial (5ml Vial)
Zoledronic Acid Injection 4mg/5ml vial
Palonosetron injection 0.25mg/5ml Vial
Icatibant Acetate Injection 30mg/ 3ml PFS
Peg Filgrastim injection 6mg/0.6m PFS
Sugammadex Sodium Injection 100mg/ml - 2ml & 5ml vial
Regadenoson Monohydrate Injection 0.4mg/5ml
Glycopyrrolate Injection 0.2mg/ml in 1ml, 2ml, 5ml & 20ml vial
Etelcalcetide Injection 2.5mg/0.5ml, 5 mg/ml, 10 mg/2ml

Injectable US: filed 9 ANDAs, 4 approved, 1 launched, 4 under review

Injectable EU/UK: 4 Filed, 3 approved, 1 commercial

Injectable Emerging market: 24 Filed, 11 approved, 8 commercial

For more information about our existing portfolio and our pipeline products please e-mail us at info@usv.in

Disclaimer: Products under patents are offered for sale only in those countries where patents have expired.






© 2022 USV Private Limited. All Rights Reserved.